Physician profile

Heather Saunders

Family · Maryville, TN

NPI 1184143174

$4,813.44

in general payments reported to CMS, 2019-2025

38 companies · $2,013 in 2025

The $2,013 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,361.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novo Nordisk INC $878.49 2021-2025 Ozempic, Rybelsus, Wegovy
Astrazeneca Pharmaceuticals LP $611.05 2022-2025 Airsupra, Farxiga, Breztri
Abbvie INC. $552.39 2022-2025
Pfizer INC. $460.02 2022-2025
Glaxosmithkline, LLC. $413.03 2021-2025 Trelegy Ellipta, Shingrix, Arexvy
Lilly USA, LLC $311.81 2022-2025 Mounjaro, Zepbound, Jardiance
Otsuka America Pharmaceutical, INC. $231.15 2023-2025 Rexulti
Dexcom, INC. $164.62 2024-2025 Dexcom G6 Transmitter
Xeris Pharmaceuticals, INC. $81.53 2024-2025 Gvoke Hypopen
Bayer Healthcare Pharmaceuticals INC. $81.00 2024-2025
Exact Sciences Corporation $73.82 2023-2025 Cologuard Collection Kit
Abbott Laboratories $71.33 2022-2023 Freestyle Libre 3
Lundbeck LLC $67.88 2021-2024 Rexulti
Shield Therapeutics INC $61.87 2023 Accrufer
Amgen INC. $58.70 2022-2024 Repatha, Otezla
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Boehringer Ingelheim Pharmaceuticals, INC. $58.20 2023-2025 Ofev, Jardiance
Merck Sharp & Dohme LLC $52.32 2024-2025 Capvaxive, Gardasil 9, Enflonsia
Esperion Therapeutics, INC. $51.91 2024 Nexletol
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $45.53 2025 Caplyta
Axsome Therapeutics, INC. $44.24 2024 Auvelity
Sumitomo Pharma America, INC. $43.05 2024-2025 Gemtesa
Sanofi-Aventis U.S. LLC $42.15 2025
E.R. Squibb & Sons, L.L.C. $39.77 2021
Regeneron Healthcare Solutions, INC. $34.64 2025 Dupixent
Takeda Pharmaceuticals U.S.A., INC. $34.40 2023-2024 Trintellix
Kowa Pharmaceuticals America, INC. $28.63 2025 Zoryve
Dynavax Technologies Corporation $26.29 2022-2024 Heplisav-B
Astellas Pharma US INC $22.57 2023 Veozah
Ars Pharmaceuticals Operations, INC. $20.38 2025 Neffy
Nevro Corp. $20.27 2024 Senza
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $20.23 2021
Kyowa Kirin, INC. $19.95 2024 Crysvita
Biohaven Pharmaceuticals, INC. $19.50 2021
Edwards Lifesciences Corporation $18.38 2023
Seqirus USA INC $16.86 2025 Flucelvax, Fluad
Antares Pharma, INC. $14.92 2023 Xyosted, Tlando, Nocdurna
Novartis Pharmaceuticals Corporation $12.72 2022
Inogen, INC. $7.84 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Heather Saunders

$4,813.44

in general payments reported 2019-2025

Years
2021-2025
Top company
Novo Nordisk INC
Context
The $2,013 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).

https://glasscript.com/doctor/10849323/heather-saunders

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.